Skip to main content

Table 1 Summary of in vivo magnolol effect on cardiovascular system

From: Cardiovascular protection of magnolol: cell-type specificity and dose-related effects

Dosage

Effect

Reference

Low (10 -7~ 10 -4  mg/kg)

10-7~−6 mg/kg (i.v.)

Prevent post MI‒induced ventricular arrythmia

[16, 18]

10-5 mg/kg (i.v.)

Decrease MI‒induced infarct size

[16]

Moderate (10 -4~ 10 -2  mg/kg)

10-4~−3 mg/kg (i.v.)

Protect myocardium against MI‒induced myocardial wall thinning

[19]

2-5 × 10-4 mg/kg (i.v.)

Decrease neutrophil infiltration in infarct heart

[20]

10-3 mg/kg (i.m.) daily

Attenuate balloon‒induced intimal thickening and inhibit LDL oxidation

[24]

10-3 mg/kg (i.m.) daily

Attenuate hypercholesteremia‒induced intimal thickening, TNFα and VCAM‒1 elevation in an aorta.

[40]

High (≧10 -1  mg/kg)

10-1 mg/kg (i.v.)

Reduce coronary artery resistance after MI

[21]

10 mg/kg (i.p.)

Prevent MI‒induced cardiomyocyte apoptosis

[22]

  1. i.v.: intravenous injection; i.m.: intramuscular injection; i.p.: intraperitoneal injection.